| Code | CSB-RA023602MB2HU |
| Size | US$9799 |
| Order now | |
| Have Questions? | Leave a Message or Start an on-line Chat |
This recombinant monoclonal antibody is a research-grade biosimilar to CNTO-5, designed for research targeting Toll-like receptor 3 (TLR3). TLR3 is a pattern recognition receptor primarily localized in endosomes that detects double-stranded RNA, a molecular signature of viral infection. Upon activation, TLR3 triggers innate immune responses through the TRIF-dependent signaling pathway, leading to production of type I interferons and pro-inflammatory cytokines. This receptor plays critical roles in antiviral immunity, and its dysregulation has been implicated in various pathological conditions including viral infections, autoimmune diseases, cancer, and inflammatory disorders.
CNTO-5 is a well-characterized neutralizing antibody that has been employed in studies investigating TLR3-mediated immune responses and inflammatory pathways. This biosimilar provides researchers with a reliable tool for exploring TLR3 biology, examining its role in innate immunity, studying viral recognition mechanisms, and investigating therapeutic interventions in TLR3-associated diseases. The antibody is valuable for experiments aimed at understanding how TLR3 signaling contributes to disease pathogenesis and for evaluating potential immunomodulatory strategies.
There are currently no reviews for this product.